Test Price
2,800 AED✅ Home Collection Available
DDX59 Gene Orofaciodigital Syndrome Type 5 Genetic Test in UAE | 2800 AED | DHA-Licensed Diagnostic Precision
Executive Summary & Core Metrics
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- ✓ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available Daily from 8 AM to 11 PM – scheduled at your convenience.
- ✓ Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed expert.
- ✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This Next-Generation Sequencing (NGS) test precisely analyzes the DDX59 gene to confirm or exclude a diagnosis of Orofaciodigital Syndrome Type 5 (OFD5), a rare autosomal recessive dysmorphology disorder. Conducted in our DHA-licensed facility, it provides definitive molecular insights within 3–4 weeks. The assay covers the entire coding region and splice sites of the DDX59 gene, achieving an analytical sensitivity and specificity of 99.9%.
| Feature | Our Test (DDX59 NGS) | Closest Alternative (Single-Gene Sanger) |
|---|---|---|
| Precision | 99.9% analytical sensitivity & specificity | ~95% for targeted regions |
| Method | NGS – covers entire coding region | Sanger sequencing – limited to PCR amplicons |
| Speed (TAT) | 3–4 weeks | 4–6 weeks (often requires multiple runs) |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics dedicated to paediatric dysmorphology, I recognise the profound impact a precise diagnosis has on families. This NGS test provides the molecular certainty required to tailor management and offer genetic counselling, yet every result must be interpreted alongside a thorough clinical evaluation. Our team will guide you through this journey with compassion and expertise.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Safety Advisory & Clinical Guidance
⚠ Exclusion Criteria & ER Red Flags
- Samples that are hemolyzed, clotted, or collected in non-standard containers will be rejected.
- This test requires mandatory guardian consent for minors under the provisions of Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Patients experiencing acute medical emergencies (e.g., respiratory distress, seizures) should visit the nearest ER before considering elective genetic testing.
- Do not use test results as a standalone basis for urgent clinical decisions; always consult a DHA-licensed paediatrician or geneticist.
Important Medication Advisory
⚠ Do not discontinue or alter prescribed medication without consulting your doctor. This test does not replace ongoing medical management.
Patient FAQ & Clinical Guidance
1. How long does the test take?
The result is typically ready within 3 to 4 weeks from the moment our ISO 9001:2015 laboratory receives your sample, ensuring no unnecessary delay in your diagnostic journey. Rare technical repeats may extend this by a few days.
2. Is a doctor's referral necessary?
Yes, a mandatory referral from a DHA-licensed paediatrician, neonatologist, or clinical geneticist is required, along with a pre-test genetic counselling session to draw a pedigree chart. This ensures the test is clinically indicated and your family history is properly assessed.
3. How is the sample collected and transported?
Our VIP home collection service uses ISO-certified cold-chain logistics to draw whole blood or a simple finger-prick onto an FTA card, delivered to the laboratory within strict temperature controls. Extracted DNA from a referral lab is also accepted in a sterile, labelled tube.
UAE Regulatory & Data Privacy Adherence
Your data is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic information is encrypted, stored in UAE-based secure servers, and never shared with third parties without your explicit consent. Clinical procedures comply with Federal Decree-Law No. 4 of 2016 on Medical Liability to ensure patient safety and informed consent.
Clinical & Logistical Metadata
| Test Name | DDX59 Gene Orofaciodigital Syndrome Type 5 Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks (21–28 calendar days) |
| Sample Type / Matrix | Whole blood (EDTA) or FTA card finger-prick; also accepts extracted genomic DNA |
| Methodology Used | Next-Generation Sequencing (NGS) – full coding region and splice site analysis |
| ICD-10-CM Code | Q87.0, Q87.8 |
| LOINC Code | 94223-5 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians